BDBM636665 4-(2-(2-((2′-chloro-3′-(5-(3-(4-(methoxymethyl)bicyclo[2. 2.1]heptan-1-yl)propyl)-1-methyl-4,5,6,7-tetrahydro-1H-imidazo [4,5-c]pyridine-2-carboxamido) -2 -methyl -[1,1′-biphenyl]-3-yl)carbamoyl)-1-methyl-1,4,6,7-tetrahydro-5H-imidazo[4,5-c]pyridi n-5-yl)ethyl)bicyclo[2.2.1]heptane-1-carboxylic acid::US20230365590, Compound I-1

SMILES COCC12CCC(CCCN3CCc4c(C3)nc(C(=O)Nc3cccc(c3Cl)-c3cccc(NC(=O)c5nc6CN(CCC78CCC(CC7)(C8)C(O)=O)CCc6n5C)c3C)n4C)(CC1)C2

InChI Key InChIKey=CAMDKWCKZXWIKF-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 636665   

TargetProgrammed cell death 1 ligand/protein 1(Human)
Shenzhen Chipscreen Biosciences

US Patent
LigandPNGBDBM636665(US20230365590, Compound I-1 | 4-(2-(2-((2′-c...)
Affinity DataIC50: 1.47nMAssay Description:The experiment process was carried out according to the flow required in the operating manual of the test reagent.The process was as follows:(1) Expe...More data for this Ligand-Target Pair
In Depth
Date in BDB:
1/12/2024
Entry Details
Go to US Patent